Loading...

DiaSorin S.p.A.

DSRLFPNK
HealthcareMedical - Diagnostics & Research
$104.69
$0.00(0.00%)

DiaSorin S.p.A. (DSRLF) Financial Performance & Statements

Review DiaSorin S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.

Revenue Growth
3.20%
3.20%
Operating Income Growth
9.56%
9.56%
Net Income Growth
17.68%
17.68%
Operating Cash Flow Growth
15.12%
15.12%
Operating Margin
23.04%
23.04%
Gross Margin
65.83%
65.83%
Net Profit Margin
16.40%
16.40%
ROE
9.17%
9.17%
ROIC
0.00%

DiaSorin S.p.A. (DSRLF) Financial Statements

Explore quarterly and annual reports including balance sheet, income statement, cash flow for DiaSorin S.p.A. stock.

MetricQ2 2024Q1 2024Q4 2023Q3 2023
Revenue$300.21M$289.00M$302.21M$270.00M
Cost of Revenue$102.27M$97.00M$107.02M$102.00M
Gross Profit$197.93M$192.00M$195.19M$168.00M
Gross Profit Ratio$0.66$0.66$0.65$0.62
R&D Expenses$21.23M$22.00M$22.95M$22.00M
SG&A Expenses$103.96M$102.00M$111.41M$100.00M
Operating Expenses$129.22M$128.00M$137.05M$130.00M
Total Costs & Expenses$231.49M$225.00M$244.07M$232.00M
Interest Income$0.00$0.00$1.92M$6.00M
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$3.66M$25.97M$71.89M$26.79M
EBITDA$74.56M$63.00M$81.48M$48.00M
EBITDA Ratio$0.25$0.31$0.27$0.28
Operating Income$70.90M$64.00M$55.51M$49.00M
Operating Income Ratio$0.24$0.22$0.18$0.18
Other Income/Expenses (Net)-$6.87M-$5.00M-$160.04M-$16.00M
Income Before Tax$64.03M$60.00M$56.22M$32.00M
Income Before Tax Ratio$0.21$0.21$0.19$0.12
Income Tax Expense$14.53M$14.00M$9.71M$7.00M
Net Income$50.006M$46.00M$47.85M$25.00M
Net Income Ratio$0.17$0.16$0.16$0.09
EPS$0.94$0.86$0.90$0.47
Diluted EPS$0.94$0.86$0.90$0.47
Weighted Avg Shares Outstanding$53.32M$53.36M$53.36M$53.29M
Weighted Avg Shares Outstanding (Diluted)$53.32M$53.36M$53.36M$53.29M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions